The suit by GenBioPro, the generic maker of mifepristone, is the latest strand in the intense legal battle over abortion pills.
Category: Federal-State Relations (US)
-
Abortion Ruling Could Undermine the F.D.A.’s Drug-Approval Authority
Legal scholars say the ruling by a Texas judge, if upheld, could spur disputes over many medications and upend the drug industry’s reliance on the agency.
-
Health Plans No Longer Have to Cover All Preventive Care at No Cost. Here’s What to Know.
The New York Times – Business:A ruling by a federal judge this week could set up yet another Supreme Court challenge to the Obamacare health law.
-
New Lawsuit Challenges State Bans on Abortion Pills
The New York Times – Business:The case, brought by GenBioPro, a company that makes one of two abortion drugs, argues that it is unconstitutional for a state to bar access to a medication approved by the federal government.
-
Supreme Court Refuses to Block California’s Ban on Flavored Tobacco
The New York Times – Business:The state’s voters had overwhelmingly supported letting a two-year-old law take effect, and lower courts had refused to put it on hold.